Skip to content

CAP48 - Autism in Children and Adolescents

CAP48 Medical Research Project: Autism Spectrum Disorders in Children and Adolescents

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06149468
Acronym
CAP48-ASD
Enrollment
500
Registered
2023-11-29
Start date
2023-09-15
Completion date
2028-12-31
Last updated
2025-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Brief summary

Evaluation and follow-up of children diagnosed with an autism spectrum disorder in French-speaking Belgium in order to optimize diagnostic protocols, the quality of care required and its accessibility, and to determine the impact of an autism spectrum disorder on schooling, family and society.

Detailed description

The aims of the research project: * To collect a wide range of data in order to improve knowledge of children with autism spectrum disorder (ASD) in French-speaking Belgium by prospectively including all children and adolescents making a request to the centres of reference. The creation of a common database will make it possible to collect general socio-demographic, geographical and epidemiological data, to characterise the different profiles and to accurately monitor developmental trajectories. * Evaluate the feasibility and practical implementation of the treatment proposed following a diagnosis of ASD in a child. * Implement protocols to improve the quality of care for beneficiaries. * To enable the development of fundamental research protocols. Many questions remain unanswered about the genetic, neuro-cognitive and linguistic characteristics of autism. Only rigorous studies carried out on large, carefully defined samples can advance research. * Increase public knowledge and understanding of the ASD.

Interventions

OTHERinclusion in the register

socio-demographic data collection and proposed therapy

Sponsors

Université Libre de Bruxelles
CollaboratorOTHER
Université de Namur
CollaboratorUNKNOWN
University of Mons
CollaboratorOTHER
Université de Liège
CollaboratorOTHER
Université Catholique de Louvain
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* children/adolescents (under 18 years of age) who apply to an autism reference center or who are followed up in an autism reference center from French-speaking region of Belgium.

Exclusion criteria

* refusal by the family to allow their child's data to be included in the database.

Design outcomes

Primary

MeasureTime frameDescription
Creation of an ADS registerThroughout the entire study, approximately during 5 yearscreation of a common ASD register to collect general sociodemographic, geographic and epidemiological data, characterize the different patient profiles and accurately track development trajectories

Secondary

MeasureTime frameDescription
Feasability assessmentThroughout the entire study, approximately during 5 yearsEvaluate the feasibility and practical realization of the proposed care following a diagnosis of ASD in a child and implement protocols to improve the quality of therapy.
Protocols developmentThroughout the entire study, approximately during 5 yearsEnable the development of fundamental research protocols: genetic, neurocognitive and linguistic
Schooling evaluationThroughout the entire study, approximately during 5 yearsEvaluate the schooling of children with ASD of all ages

Countries

Belgium

Contacts

Primary ContactMarie-Cécile Nassogne, Prof
marie-cecile.nassogne@saintluc.uclouvain.be027641061
Backup ContactMarine Houssa, PhD
marine.houssa@uclouvain.be010474688

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026